756 related articles for article (PubMed ID: 16391903)
1. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
Ramachandran A; Snehalatha C; Mary S; Mukesh B; Bhaskar AD; Vijay V;
Diabetologia; 2006 Feb; 49(2):289-97. PubMed ID: 16391903
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).
Ramachandran A; Snehalatha C; Yamuna A; Mary S; Ping Z
Diabetes Care; 2007 Oct; 30(10):2548-52. PubMed ID: 17670917
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).
Ramachandran A; Snehalatha C; Mary S; Selvam S; Kumar CK; Seeli AC; Shetty AS
Diabetologia; 2009 Jun; 52(6):1019-26. PubMed ID: 19277602
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
Ramachandran A; Arun N; Shetty AS; Snehalatha C
Diabetes Care; 2010 Oct; 33(10):2164-8. PubMed ID: 20519663
[TBL] [Abstract][Full Text] [Related]
5. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).
Snehalatha C; Mary S; Selvam S; Sathish Kumar CK; Shetty SB; Nanditha A; Ramachandran A
Diabetes Care; 2009 Oct; 32(10):1796-801. PubMed ID: 19587369
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.
Snehalatha C; Mary S; Joshi VV; Ramachandran A
Diab Vasc Dis Res; 2008 Mar; 5(1):25-9. PubMed ID: 18398809
[TBL] [Abstract][Full Text] [Related]
8. A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial.
Wijesuriya M; Fountoulakis N; Guess N; Banneheka S; Vasantharajah L; Gulliford M; Viberti G; Gnudi L; Karalliedde J
BMC Med; 2017 Aug; 15(1):146. PubMed ID: 28851373
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
[TBL] [Abstract][Full Text] [Related]
10. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
[TBL] [Abstract][Full Text] [Related]
11. Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons - results of further analyses of DIABRISK-SL in those below 18 years of age.
Fountoulakis N; Wijesuriya M; Gnudi L; Gulliford M; Karalliedde J
BMC Med; 2019 Sep; 17(1):162. PubMed ID: 31533827
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
13. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
14. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
[TBL] [Abstract][Full Text] [Related]
15. Relationship of body size and shape to the development of diabetes in the diabetes prevention program.
Diabetes Prevention Program Research Group
Obesity (Silver Spring); 2006 Nov; 14(11):2107-17. PubMed ID: 17135629
[TBL] [Abstract][Full Text] [Related]
16. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
[TBL] [Abstract][Full Text] [Related]
17. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
Ratner RE; Christophi CA; Metzger BE; Dabelea D; Bennett PH; Pi-Sunyer X; Fowler S; Kahn SE;
J Clin Endocrinol Metab; 2008 Dec; 93(12):4774-9. PubMed ID: 18826999
[TBL] [Abstract][Full Text] [Related]
18. Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.
Jenum AK; Brekke I; Mdala I; Muilwijk M; Ramachandran A; Kjøllesdal M; Andersen E; Richardsen KR; Douglas A; Cezard G; Sheikh A; Celis-Morales CA; Gill JMR; Sattar N; Bhopal RS; Beune E; Stronks K; Vandvik PO; van Valkengoed IGM
Diabetologia; 2019 Aug; 62(8):1337-1348. PubMed ID: 31201437
[TBL] [Abstract][Full Text] [Related]
19. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
[TBL] [Abstract][Full Text] [Related]
20. Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program.
Nanditha A; Ram J; Snehalatha C; Selvam S; Priscilla S; Shetty AS; Arun R; Godsland IF; Johnston DG; Ramachandran A
Diabetes Care; 2014 Nov; 37(11):3009-15. PubMed ID: 25216506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
